TP53 and hepatocellular carcinoma: Overexpression of SIRT3 decreases HCC cell proliferation and promotes apoptosis through multiple mechanisms, including the activation of the GSK-3β/Bax signalling pathway [196], upregulation of p53 [198], and reduction in Mdm2-mediated p53 degradation [199].